 BOSTON, July 06, 2022 GLOBE NEWSWIRE -- Entrada Therapeutics, Inc. Nasdaq: TRDA, a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle EEVTM therapeutics as a new class of medicines, today announced that the Company will participate in-person at the William Blair Biotech Focus Conference, to be held in New York from July 12 13, 2022. 